Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arrowhead Pharmaceuticals

10.68
-1.3800-11.44%
Post-market: 10.680.00000.00%18:43 EDT
Volume:2.57M
Turnover:27.99M
Market Cap:1.47B
PE:-2.07
High:11.96
Open:11.74
Low:10.66
Close:12.06
Loading ...
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Nov 26, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 10, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Major Issues Report

Form 8-K - Current report